Efficacy and Safety of Secondary Prophylactic Versus On-Demand Sucrose-Formulated Recombinant Factor VIII Treatment in Adults with Severe Hemophilia A: Results from a 13-Month Crossover Study

被引：0
|
作者：
Collins, Peter [1 ]
Faradji, Albert [2 ]
Morfini, Massimo [3 ]
Enriquez, Monika Maas [4 ]
Gorina, Eduard [5 ]
Schwartz, Lawrence [6 ]
Lemm, Georg [5 ]
机构：
[1] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales
[2] Hautepierre Hosp, Strasbourg, France
[3] Univ Hosp, Florence, Italy
[4] Bayer HealthCare, Wuppertal, Germany
[5] Bayer HealthCare Pharmaceut, Berkeley, CA USA
[6] Bayer HealthCare Pharmaceut, Montville, NJ USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 33 条
  • [1] Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study
    Collins, P.
    Faradji, A.
    Morfini, M.
    Enriquez, M. M.
    Schwartz, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) : 83 - 89
  • [2] Efficacy of secondary prophylactic versus on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia a with and without target joints
    Collins, P.
    Faradji, A.
    Morfini, M.
    Enriquez, Maas M.
    Schwartz, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1128 - 1128
  • [3] Randomized, controlled, parallel-group trial of secondary prophylaxis vs on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A
    Kempton, C.
    Valluri, S.
    Reding, M.
    Lissitchkov, T.
    Goranov, S.
    Gercheva, L.
    Rusen, L.
    Ghinea, M.
    Uscatescu, V.
    Rescia, V.
    Hong, W.
    Manco-Johnson, M.
    HAEMOPHILIA, 2012, 18 (05) : 830 - 831
  • [4] Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with hemophilia A
    Yong, J.
    Liu, H.
    Hsueh, E.
    Huang, M.
    Peng, C.
    Chen, R.
    Maas-Enriquez, M.
    Haupt, V.
    HAEMOPHILIA, 2008, 14 : 13 - 13
  • [5] Bleeding frequency subanalyses in a randomized controlled trial of prophylaxis vs on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A
    Zarkova, A. G.
    Kempton, C. L.
    Reding, M. T.
    Lissitchkov, T.
    Goranov, S.
    Gercheva, L.
    Rusen, L.
    Ghinea, M.
    Uscatescu, V.
    Rescia, V.
    Hong, W.
    Manco-Johnson, M. J.
    HAEMOPHILIA, 2013, 19 : 28 - 29
  • [6] A multicenter, international clinical trial on safety and efficacy of sucrose-formulated recombinant factor VIII for treatment of hemophilia A
    Brackmann, HH
    Abshire, T
    Scharrer, I
    Hoots, K
    Gazengel, C
    Powell, JS
    Gorina, E
    Kellermann, E
    Vosburgh, E
    THROMBOSIS AND HAEMOSTASIS, 1999, : 472 - 472
  • [7] 3-year results from SPINART: prophylaxis vs on-demand treatment with sucrose-formulated recombinant factor VIII
    Manco-Johnson, Marilyn J.
    Kempton, Christine L.
    Reding, Mark T.
    Goranov, Stefcho
    Gercheva, Liana
    Rusen, Luminita
    Uscatescu, Valentina
    Pierdominici, Marta
    Walker, Dale
    Hong, Walter
    HAEMOPHILIA, 2014, 20 : 96 - 96
  • [8] Bleeding events in Chinese children with severe hemophilia A receiving standard prophylaxis vs on-demand treatment with Bayer's sucrose-formulated recombinant factor VIII
    Zhao, Y.
    Xiao, J.
    Yang, R.
    Wu, R.
    Hu, Y.
    Beckmann, H.
    Wu, J.
    Hou, D.
    Sun, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 858 - 858
  • [9] Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
    Manco-Johnson, M. J.
    Kempton, C. L.
    Reding, M. T.
    Lissitchkov, T.
    Goranov, S.
    Gercheva, L.
    Rusen, L.
    Ghinea, M.
    Uscatescu, V.
    Rescia, V.
    Hong, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (06) : 1119 - 1127
  • [10] Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A
    Zhao, Yongqiang
    Xiao, Juan
    Yang, Renchi
    Wu, Runhui
    Hu, Yu
    Beckmann, Horst
    Wu, Junde
    Hou, Qingsong
    Sun, Jing
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (03) : 138 - 148
1234